Kristy Berry

1.0k total citations
18 papers, 71 citations indexed

About

Kristy Berry is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kristy Berry has authored 18 papers receiving a total of 71 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Kristy Berry's work include Phosphodiesterase function and regulation (7 papers), Cancer Mechanisms and Therapy (4 papers) and Ubiquitin and proteasome pathways (4 papers). Kristy Berry is often cited by papers focused on Phosphodiesterase function and regulation (7 papers), Cancer Mechanisms and Therapy (4 papers) and Ubiquitin and proteasome pathways (4 papers). Kristy Berry collaborates with scholars based in United States, Germany and Canada. Kristy Berry's co-authors include Zhican Qu, Traci N. Bethea, Yonghe Li, Cuihong Lin, Wenyan Lü, Ling Zhai, William R. Waud, Mathias Leblanc, Jon D. Reuter and Adam B. Keeton and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Kristy Berry

13 papers receiving 70 citations

Peers

Countries citing papers authored by Kristy Berry

Since Specialization

Citations

This map shows the geographic impact of Kristy Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristy Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristy Berry more than expected).

Fields of papers citing papers by Kristy Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristy Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristy Berry. The network helps show where Kristy Berry may publish in the future.

Co-authorship network of co-authors of Kristy Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Kristy Berry. A scholar is included among the top collaborators of Kristy Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristy Berry. Kristy Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Highly specific Immunoproteasome inhibitor M3258 induces proteotoxic stress and apoptosis in KMT2A::AFF1 driven acute lymphoblastic leukemia 2025 ·Scientific Reports ·(unknown), (unknown), Ji Eun Park, Aaron Wilson, Kristy Berry, Keith S. Wong, Walid A. Houry, Tai-Lin Lee, (unknown), Peter Panizzi, (unknown), Matthew Shane Loop, Amit Mitra, Alexei F. Kisselev	3
2	Abstract 3323: Novel Pan-RAS inhibitor ADT-007: A unique mechanism of antitumor selectivity in pancreatic and colorectal carcinoma models 2024 ·Cancer Research ·Junwei Wang, Adam B. Keeton, Sindhu Ramesh, (unknown), (unknown), Jeremy B. Foote, (unknown), Kristy Berry, (unknown), (unknown), Ganji Purnachandra Nagaraju, Elmar Nurmemmedov, Ivan Babić, Vadim Gaponenko, (unknown), Bassel F. El‐Rayes, Donald J. Buchsbaum, Gary A. Piazza	1
3	A potent and selective pan-RAS inhibitor, ADT-1004, targeting complex KRAS mutations for pancreatic cancer. 2024 ·Journal of Clinical Oncology ·Gary A. Piazza, (unknown), (unknown), Jeremy B. Foote, Adam B. Keeton, (unknown), (unknown), (unknown), Kristy Berry, Yulia Maxuitenko, Upender Manne, Michael R. Boyd, Donald J. Buchsbaum, Bassel F. El‐Rayes	0
4	Evaluation of a novel Pan-RAS/β-Catenin inhibitor, ADT-030, for treatment of pancreatic cancer. 2024 ·Journal of Clinical Oncology ·Gary A. Piazza, (unknown), (unknown), Jeremy B. Foote, Adam B. Keeton, (unknown), (unknown), (unknown), Kristy Berry, Yulia Maxuitenko, Upender Manne, Donald J. Buchsbaum, Bassel F. El‐Rayes, Michael R. Boyd	0
5	Novel Celecoxib Derivative, RF26, Blocks Colon Cancer Cell Growth by Inhibiting PDE5, Activating cGMP/PKG Signaling, and Suppressing β-catenin-dependent Transcription 2024 ·Anti-Cancer Agents in Medicinal Chemistry ·(unknown), Mohammad Abdel‐Halim, (unknown), Luciana Madeira da Silva, Adam B. Keeton, Yulia Maxuitenko, Kristy Berry, Gang Zhou, Matthias Engel, Alireza Abadi, Gary A. Piazza, (unknown)	2
6	Novel sulindac derivatives for colorectal cancer chemoprevention that target cGMP phosphodiesterases to suppress Wnt/β-catenin transcriptional activity 2023 ·Sindhu Ramesh, (unknown), (unknown), (unknown), (unknown), Kristy Berry, Yulia Maxuitenko, Xi Chen, Adam B. Keeton, Gang Zhou, Gary A. Piazza	2
7	Novel sulindac derivatives for colorectal cancer chemoprevention that target cGMP phosphodiesterases to suppress Wnt/β-catenin transcriptional activity 2023 ·Sindhu Ramesh, (unknown), (unknown), (unknown), (unknown), Kristy Berry, Yulia Maxuitenko, Xi Chen, Adam B. Keeton, Gang Zhou, Gary A. Piazza	1
8	Abstract 1658: ADT-007 binds RAS and inhibits RAS signaling 2023 ·Cancer Research ·Adam B. Keeton, (unknown), (unknown), (unknown), (unknown), (unknown), Jeremy B. Foote, Donald J. Buchsbaum, Kristy Berry, Elmar Nurmemmedov, Ivan Babić, Vadim Gaponenko, Gregory S. Gorman, Lori Coward, Yulia Maxuitenko, Forrest Smith, Gary A. Piazza	1
9	Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer 2022 ·Journal of Ovarian Research ·(unknown), Elaine Gavin, Alla Musiyenko, Wito Richter, Kevin J. Lee, David K. Crossman, Joel Andrews, (unknown), Steven McClellan, Ileana Aragon, (unknown), Xi Chen, Adam B. Keeton, Kristy Berry, Gary A. Piazza, Jennifer Scalici, Luciana Madeira da Silva	13
10	Abstract 1213: PDE10A as a novel target to suppress Wnt/β-catenin signaling and other oncogenic pathways in ovarian cancer 2021 ·Cancer Research ·(unknown), Elaine Gavin, Alla Musiyenko, Wito Richter, Kevin J. Lee, (unknown), Joel Andrews, Steve McClellan, Ileana Aragon, (unknown), Xi Chen, Adam B. Keeton, Kristy Berry, Gary A. Piazza, Jennifer Scalici, Luciana Madeira da Silva	0
11	Abstract 345: Novel RAS inhibitor, MCI-062, potently and selectively inhibits the growth of KRAS mutant pancreatic tumor cells by blocking GTP loading of RAS 2019 ·Cancer Research ·(unknown), Xi Chen, (unknown), Yulia Maxuitenko, Bing Zhu, (unknown), Verónica Ramírez‐Alcántara, Kristy Berry, Michael J. Boyd, Adam B. Keeton, Gary A. Piazza	2
12	Abstract 2707: A novel RAS inhibitor, MCI-062, inhibits colon tumor growth in vivo and activates antitumor immunity 2019 ·Immunology ·Adam B. Keeton, (unknown), Xi Chen, (unknown), Bing Zhu, Verónica Ramírez‐Alcántara, Yulia Maxuitenko, Kristy Berry, (unknown), Michael R. Boyd, Gary A. Piazza	1
13	Abstract 2707: A novel RAS inhibitor, MCI-062, inhibits colon tumor growth in vivo and activates antitumor immunity 2019 ·Cancer Research ·Adam B. Keeton, (unknown), Xi Chen, (unknown), Bing Zhu, Verónica Ramírez‐Alcántara, Yulia Maxuitenko, Kristy Berry, (unknown), Michael R. Boyd, Gary A. Piazza	5
14	Abstract B54: Targeting constitutively active RAS signaling in high-grade serous ovarian carcinoma (HGSOC) with ADT-006, a novel small molecule that blocks RAS-effector interactions 2018 ·Clinical Cancer Research ·Luciana Madeira da Silva, (unknown), Adam B. Keeton, Bing Zhu, Kristy Berry, Alla Musiyenko, Elaine Gavin, Kevin Lee, Verónica Ramírez‐Alcántara, Yulia Maxuitenko, Xi Chen, (unknown), Michael R. Boyd, Jennifer Scalici, Rodney P. Rocconi, Gary A. Piazza	1
15	Abstract 1140: Characterization of a novel PDE10 inhibitor in lung tumor cells and an orthotopic mouse model of lung cancer 2017 ·Cancer Research ·Verónica Ramírez‐Alcántara, Bing Zhu, Xi Chen, Rajkumar Savai, (unknown), (unknown), Kevin J. Lee, (unknown), Kristy Berry, Dennis Otali, Joshua C. Canzoneri, (unknown), Adam B. Keeton, Lori Coward, Gregory S. Gorman, William E. Grizzle, Michael J. Boyd, Gary A. Piazza	1
16	Abstract 5174: Phosphodiesterase 10A inhibition as a novel approach to suppress β-catenin signaling in ovarian cancer cells 2017 ·Cancer Research ·Luciana Madeira da Silva, Elaine Gavin, Kevin J. Lee, Verónica Ramírez‐Alcántara, Kristy Berry, (unknown), Alla Musiyenko, Ileana Aragon, Adam B. Keeton, Jennifer Scalici, Rodney P. Rocconi, Gary A. Piazza	0
17	Brain abscess in a rhesus macaque (Macaca mulatta) with a cephalic implant. 2013 ·PubMed ·Mathias Leblanc, Kristy Berry, (unknown), Jon D. Reuter	9
18	Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo 2011 ·FEBS Letters ·Cuihong Lin, Wenyan Lü, Ling Zhai, Traci N. Bethea, Kristy Berry, Zhican Qu, William R. Waud, Yonghe Li	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact